| 653598 |
FRONTIERS IN ONCOLOGY |
Medication for Acromegaly Reduces Expression of MUC16, MACC1 and GRHL2 in Pituitary Neuroendocrine Tumour Tissue |
2021-02-15 |
10.3389/fonc.2020.593760 |
Saksis Rihards, Silamikelis Ivars, Laksa Pola, Megnis Kaspars, Peculis Raitis, Mandrika Ilona, Rogoza Olesja, Petrovska Ramona, Balcere Inga, Konrade Ilze, Steina Liva, Stukens Janis, Breiksa Austra, Nazarovs Jurijs, Sokolovska Jelizaveta, Pirags Valdis, Klovins Janis, Rovite Vita |
| 653597 |
FRONTIERS IN ONCOLOGY |
miR-483-3p, Mediated by KLF9, Functions as Tumor Suppressor in Testicular Seminoma via Targeting MMP9 |
2021-02-15 |
10.3389/fonc.2020.596574 |
Zhang Lei, Ruan Yashi, Qin Zhiqiang, Gao Xian, Xu Kai, Shi Xiaokai, Gao Shenglin, Liu Shouyong, Zhu Kai, Wang Wei, Zuo Li, Zhang Lifeng, Zhang Wei |
| 653596 |
FRONTIERS IN ONCOLOGY |
Three-Dimensional Ex Vivo Culture for Drug Responses of Patient-Derived Gastric Cancer Tissue |
2021-02-15 |
10.3389/fonc.2020.614096 |
Chen Sian, Chen Chenbin, Hu Yuanbo, Zhu Ce, Luo Xiaozhi, Wang Lizhu, Wang Xiang, Sun Xiangwei, Chen Xiaodong, Xie Wangkai, Lou Han, Huang Xielin, Li Chao, Xu Jun, Xue Xiangyang, Shen Xian |
| 653595 |
FRONTIERS IN ONCOLOGY |
Survival Status of Esophageal Cancer Patients and its Determinants in Ethiopia: A Facility Based Retrospective Cohort Study |
2021-02-15 |
10.3389/fonc.2020.594342 |
Hassen Hamid Yimam, Teka Mohammed Ahmed, Addisse Adamu |
| 653594 |
FRONTIERS IN GENETICS |
SARS CoV-2 Spike Protein in silico Interaction With ACE2 Receptors From Wild and Domestic Species |
2021-02-15 |
10.3389/fgene.2021.571707 |
Rendon-Marin Santiago, Martinez-Gutierrez Marlen, Whittaker Gary R., Jaimes Javier A., Ruiz-Saenz Julian |
| 653593 |
FRONTIERS IN IMMUNOLOGY |
Arthropods Under Pressure: Stress Responses and Immunity at the Pathogen-Vector Interface |
2021-02-15 |
10.3389/fimmu.2020.629777 |
Rosche Kristin L., Sidak-Loftis Lindsay C., Hurtado Joanna, Fisk Elizabeth A., Shaw Dana K. |
| 653592 |
FRONTIERS IN ONCOLOGY |
A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer |
2021-02-15 |
10.3389/fonc.2020.565384 |
Hu Nanlin, Zhu Anjie, Si Yiran, Yue Jian, Wang Xue, Wang Jiayu, Ma Fei, Xu Binghe, Yuan Peng |
| 653591 |
FRONTIERS IN ONCOLOGY |
Real World Experience of Daratumumab: Evaluating Lymphopenia and Adverse Events in Multiple Myeloma Patients |
2021-02-15 |
10.3389/fonc.2020.575168 |
Cottini Francesca, Huang Ying, Williams Nita, Bumma Naresh, Khan Abdullah M., Chaudhry Maria, Devarakonda Srinivas, Efebera Yvonne A., Benson Don M., Rosko Ashley E. |
| 653590 |
FRONTIERS IN ONCOLOGY |
Comparative Proteome Identifies Complement Component 3-Mediated Immune Response as Key Difference of Colon Adenocarcinoma and Rectal Adenocarcinoma |
2021-02-15 |
10.3389/fonc.2020.617890 |
Liang Jun-Ze, Liang Xiao-Ling, Zhong Li-Ye, Wu Chu-Tian, Zhang Jing, Wang Yang |
| 653589 |
FRONTIERS IN GENETICS |
Repositioning Drugs to the Mitochondrial Fusion Protein 2 by Three-Tunnel Deep Neural Network for Alzheimer's Disease |
2021-02-15 |
10.3389/fgene.2021.638330 |
Wang Xun, Zhong Yue, Ding Mao |
